Recon: Blueprint's $250M preclinical buy; WHO, CDC, Biden react to Omicron variant

ReconReconAPIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsGlobalMedical DevicesPharmaceuticals